Venoforce I
NDC 43857-0651, Aesculus Hippocastanum, Collinsonia Canadensis, Echinacea (Angustifolia), Hamamelis Virginiana, Pulsatilla (Vulgaris), Arnica Montana, Carbo Vegetabilis, Graphites, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Paeonia Officinalis, Sepia, Hydrofluoricum Acidum, liquid, from BioActive Nutritional, Inc..
- Product NDC
- 43857-0651
- Status
- Listed
- Labeler
- BioActive Nutritional, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HORSE CHESTNUT3 [hp_X]/mL
- COLLINSONIA CANADENSIS ROOT3 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE3 [hp_X]/mL
- HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK3 [hp_X]/mL
- PULSATILLA VULGARIS WHOLE4 [hp_X]/mL
- ARNICA MONTANA WHOLE12 [hp_X]/mL
- ACTIVATED CHARCOAL12 [hp_X]/mL
- GRAPHITE12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE12 [hp_X]/mL
- NITRIC ACID12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED12 [hp_X]/mL
- PAEONIA OFFICINALIS ROOT12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE12 [hp_X]/mL
- HYDROFLUORIC ACID16 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43857-0651-1 | 43857065101 | 30 mL in 1 BOTTLE, DROPPER (43857-0651-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43857-0651 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43857-0651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.